MP58: Prostate Cancer: Detection & Screening VII

Poster Session Moderator(s)

• KL

  Kevin Loughlin, MD (he/him/his)

  Harvard Medical School
• 

  Peter Pinto, MD (he/him/his)

  National Cancer Institute, National Institutes of Health
• 

  Douglas Scherr, MD

  Weill Cornell Medical College-NY Presbyterian Hospital

Presentations:

• 1:00 PM – 2:15 PM

  MP58-01: Is MRI and fusion biopsies necessary in patients with PSA levels >10 ng/ml?
  

  Poster Presenter: Lorenzo Maria Rovesti
• 1:00 PM – 2:15 PM

  MP58-02: PSA-Density Determines the Need for Systematic Biopsy in Men with PI-RADS 4/5 MRI
  

  Poster Presenter: Zachary Feuer, MD, BS
• 1:00 PM – 2:15 PM

  MP58-03: Prostate Cancer Screening - a Novel Risk Prediction Tool with Standard Biopsies vs. PSA with MRI-Targeted Biopsies
  

  Poster Presenter: Lars Bjornebo, MSC
• 1:00 PM – 2:15 PM

  MP58-04: PSA Density Directly Correlates with PI-RADS Lesion Score on Prostate MRI
  

  Poster Presenter: Clay D. Martin, MD
• 1:00 PM – 2:15 PM

  MP58-05: Urinary smart test for early detection of prostate cancer
  

  Poster Presenter: Francesco Porpiglia, MD
• 1:00 PM – 2:15 PM

  MP58-06: Diagnostic performance of mixed targeted prostate biopsy approaches using micro-Ultrasound and MRI-fusion biopsies
  

  Poster Presenter: Davide Maffei, MD
• 1:00 PM – 2:15 PM

  MP58-07: Clinically Significant Prostate Cancer Detection Rate by PI-RADS Score and PSA-Density: A Descriptive Analysis
  

  Poster Presenter: Zachary Feuer, MD, BS
• 1:00 PM – 2:15 PM

  MP58-08: TransPERINEAL vs transRECTAL MRI/TRUS fusion prostate biopsy: a matched-pair comparison
  

  Poster Presenter: Masatomo Kaneko
• 1:00 PM – 2:15 PM

  MP58-09: Diagnostic performance of Fusion (US/MRI guided) prostate Biopsy: propensity score matched comparison of elastic versus rigid fusion system
  

  Poster Presenter: Mariaconsiglia Ferriero, MD, PHD – "Regina Elena" National Cancer Institute
• 1:00 PM – 2:15 PM

  MP58-10: A novel approach for 3D reconstruction of the prostate gland that allows tumour location, volume estimation, and Gleason characterization.
  

  Poster Presenter: Ashwin Sachdeva, PhD,MBBS – University of Manchester
• 1:00 PM – 2:15 PM

  MP58-11: Comparison of Prostate Cancer Detection Rates Between Trans-rectal MRI/US Fusion and Trans-Perineal Cognitive Targeted Prostate Biopsy Approaches
  

  Poster Presenter: Johnathan A. Drevik, MD
• 1:00 PM – 2:15 PM

  MP58-12: Additional systematic to MRI-targeted biopsy in prostate cancer diagnosis: A double-edged sword
  

  Poster Presenter: Rodrigo Suarez-Ibarrola
• 1:00 PM – 2:15 PM

  MP58-13: ATM mutations are associated with high-risk architectural features in men with familial prostate cancer
  

  Poster Presenter: Romy Fernanda Mondschein, MBBS
• 1:00 PM – 2:15 PM

  MP58-14: Discordance Between Prostate Imaging Reporting & Data System Score and Targeted Prostate Biopsy: An Opportunity for Quality Improvement
  

  Poster Presenter: Rohith Arcot, MD – Duke Urology
• 1:00 PM – 2:15 PM

  MP58-15: Assessing the role of high-resolution micro-ultrasound among patients with a negative multiparametric MRI and a persistent suspicion of prostate cancer.
  

  Poster Presenter: Pier Paolo Avolio
• 1:00 PM – 2:15 PM

  MP58-16: Does veteran status mitigate racial disparities in prostate cancer screening? Analysis of prostate-specific antigen screening patterns in the 2018 Behavioral Risk Factor Surveillance System Data
  

  Poster Presenter: Khalid Alkhatib, MD
• 1:00 PM – 2:15 PM

  MP58-17: Black-tailored Prostate Biopsy Risk Calculator Outperforms Prostate Cancer Prevention Trial 2.0.
  

  Poster Presenter: Neil A. Mistry, MD, MPH – Northwestern University
• 1:00 PM – 2:15 PM

  MP58-18: Real world application and experience of a prostate specific antigen (PSA) machine learning model in a screening population
  

  Poster Presenter: Marlon L. Perera, MD – Austin Health
• 1:00 PM – 2:15 PM

  MP58-19: Comparison of UroNav TRUS and Cognitive Fusion TP Biopsy in Detection of Clinically Significant Prostate Cancer
  

  Poster Presenter: Amanda Sherman, MD
• 1:00 PM – 2:15 PM

  MP58-20: Use of low-value prostate-specific antigen screening among young men with private insurance
  

  Poster Presenter: Jeffrey Vehawn, BA